KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 124 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $26,000 | -7.1% | 7,574 | 0.0% | 0.00% | – |
| Q2 2018 | $28,000 | -9.7% | 7,574 | 0.0% | 0.00% | – |
| Q1 2018 | $31,000 | -11.4% | 7,574 | 0.0% | 0.00% | – |
| Q4 2017 | $35,000 | +52.2% | 7,574 | +130.6% | 0.00% | – |
| Q3 2017 | $23,000 | -4.2% | 3,285 | 0.0% | 0.00% | – |
| Q2 2017 | $24,000 | +20.0% | 3,285 | 0.0% | 0.00% | – |
| Q1 2017 | $20,000 | +5.3% | 3,285 | 0.0% | 0.00% | – |
| Q4 2016 | $19,000 | +11.8% | 3,285 | 0.0% | 0.00% | – |
| Q3 2016 | $17,000 | -22.7% | 3,285 | 0.0% | 0.00% | – |
| Q2 2016 | $22,000 | +46.7% | 3,285 | 0.0% | 0.00% | – |
| Q1 2016 | $15,000 | -11.8% | 3,285 | 0.0% | 0.00% | – |
| Q4 2015 | $17,000 | +325.0% | 3,285 | +168.8% | 0.00% | – |
| Q3 2015 | $4,000 | 0.0% | 1,222 | +175.2% | 0.00% | – |
| Q2 2015 | $4,000 | -33.3% | 444 | 0.0% | 0.00% | – |
| Q1 2015 | $6,000 | – | 444 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,312,006 | $22,357,000 | 15.70% |
| VHCP Management, LLC | 1,000,273 | $17,045,000 | 8.86% |
| HARVEY CAPITAL MANAGEMENT INC | 915,800 | $15,605,000 | 6.22% |
| Baupost Group | 6,310,850 | $107,537,000 | 2.60% |
| SECTORAL ASSET MANAGEMENT INC | 3,537,590 | $60,281,000 | 2.48% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 587,504 | $10,011,000 | 2.31% |
| Knoll Capital Management, LLC | 200,000 | $3,408,000 | 1.76% |
| Camber Capital Management LP | 1,250,000 | $21,300,000 | 1.67% |
| NORTHPOINTE CAPITAL LLC | 877,875 | $14,958,000 | 1.52% |
| DAFNA Capital Management LLC | 100,000 | $1,704,000 | 1.46% |